Haemostatix
Bringing innovative solutions to manage and treat bleeding during surgeries, trauma cases, and leukemia treatment with advanced peptide-based technology.
General Information
Get notified when Haemostatix moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Haemostatix
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
Biotechnology
About Haemostatix
Taxonomy: BioCity, Nottingham, Haemostatix Ltd, surgical procedures, trauma treatment, leukemia treatment, peptide-based technology, clot formation, fibrinogen, commercialization, technology platform, spin-out, University of Leicester, first-in-class products, bleeding management
Funding Rounds & Investors (7)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Venture Round | •••••• | 1 |
|
11 Nov 2014 |
| Venture Round | •••••• | 1 |
|
05 Mar 2014 |
| Venture Round | •••••• | 6 |
|
02 Nov 2012 |
| Series C | •••••• | 4 |
|
01 Aug 2011 |
| Venture Round | •••••• | 4 |
|
11 Nov 2010 |
Haemostatix Alternatives & Competitors
Changing the paradigm for cancer treatment through the development of antigen-independent peptide dr...
Canadian biotechnology company delivering premium food, cosmetic and health ingredients isolated fro...
Innovative cancer treatment technology delivering advanced nano agents to target tumors, enhancing p...
FAQ About Haemostatix
Don't just browse. Track.
Signal Tracker monitors Haemostatix and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.